HK5493A - (s)-(-)-1-propyl-2',6'-pipecoloxylidide hydrochloride monohydrate, process for its preparation and pharmaceutical preparation containing it - Google Patents

(s)-(-)-1-propyl-2',6'-pipecoloxylidide hydrochloride monohydrate, process for its preparation and pharmaceutical preparation containing it Download PDF

Info

Publication number
HK5493A
HK5493A HK54/93A HK5493A HK5493A HK 5493 A HK5493 A HK 5493A HK 54/93 A HK54/93 A HK 54/93A HK 5493 A HK5493 A HK 5493A HK 5493 A HK5493 A HK 5493A
Authority
HK
Hong Kong
Prior art keywords
propyl
water
preparation
compound
added
Prior art date
Application number
HK54/93A
Other languages
German (de)
English (en)
Inventor
Rune Verner Sandberg
Original Assignee
Astra Lakemedel Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20363001&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK5493(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Lakemedel Aktiebolag filed Critical Astra Lakemedel Aktiebolag
Publication of HK5493A publication Critical patent/HK5493A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Claims (9)

1. Chlorhydrate de (S)-(-)-1-propyl-2',6'-pipéco- loxylidide, caractérisé en ce que le composé est sous la forme de son monohydrate.
2. Composé selon la revendication 1, caractérisé en ce qu'il est pratiquement pur optiquement.
3. Composé selon la revendication 1, caractérisé en ce qu'il contient moins de 0,5% en poids de l'énan- tiomère (R)-(+) correspondant.
4. Procédé pour la préparation du monohydrate du chlorhydrate de (S)-( )-1-propyl-2',6'-pipéco- loxylidide pratiquement pur optiquement, caractérisé en ce que l'on dissout dans de l'eau du chlorhydrate de (S)-(-)-1-propyl-2'-6'-pipécoloxylidide contenant l'énantiomère (R)-(+), puis on ajoute de l'acétone chauffée à une température dans la plage de 45°C à son point d'ébullition, et on isole le monohydrate du chlorhydrate de (S)-(-)-1-propyl-2',6'- pipécoloxylidide.
5. Procédé selon la revendication 4, caractérisé en ce que l'on dissout le chlorhydrate du (S)-(-)-1-propyl-2',6'-pipécoloxylidide dans une quantité d'eau qui correspond à 1-3 fois sont poids, on ajoute de l'acétone en un volume égal à 5-15 fois le volume d'eau, à la suite de quoi on filtre la solution et on isole le produit final.
6. Procédé selon la revendication 5, caractérisé en ce que le poids de l'eau est égal au poids du chlorhydrate du (S)-(-)-1 -propyi-2',6'-pipécoioxyii- dide et le volume de l'acétone est égal à 10 fois le volume de l'eau ajoutée.
7. Composition pharmaceutique pour anesthésie locale, caractérisée en ce qu'elle contient le composé selon la revendication 1.
8. Composition selon la revendication 1, pour utilisation dans l'induction d'anesthésie locale.
9. Utilisation du composé selon la revendication 1 dans la fabrication de compositions pharmaceutiques ayant un effet anesthésique local.
HK54/93A 1986-01-03 1993-01-21 (s)-(-)-1-propyl-2',6'-pipecoloxylidide hydrochloride monohydrate, process for its preparation and pharmaceutical preparation containing it HK5493A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8600017A SE451840B (sv) 1986-01-03 1986-01-03 Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning

Publications (1)

Publication Number Publication Date
HK5493A true HK5493A (en) 1993-01-29

Family

ID=20363001

Family Applications (1)

Application Number Title Priority Date Filing Date
HK54/93A HK5493A (en) 1986-01-03 1993-01-21 (s)-(-)-1-propyl-2',6'-pipecoloxylidide hydrochloride monohydrate, process for its preparation and pharmaceutical preparation containing it

Country Status (29)

Country Link
US (1) US4870086A (fr)
EP (1) EP0239710B1 (fr)
JP (1) JPH07598B2 (fr)
KR (1) KR940008302B1 (fr)
AR (1) AR242561A1 (fr)
AT (1) ATE56956T1 (fr)
AU (1) AU592392B2 (fr)
BG (1) BG62066B2 (fr)
CA (1) CA1276154C (fr)
CY (1) CY1680A (fr)
DE (1) DE3674582D1 (fr)
DK (1) DK171378B1 (fr)
EG (1) EG17867A (fr)
ES (1) ES2036179T3 (fr)
FI (1) FI83075C (fr)
GR (1) GR3002516T3 (fr)
HK (1) HK5493A (fr)
IE (1) IE59061B1 (fr)
LU (1) LU88843I2 (fr)
LV (1) LV5765B4 (fr)
MY (1) MY101132A (fr)
NL (1) NL960005I2 (fr)
NO (2) NO170330C (fr)
NZ (1) NZ218615A (fr)
PH (1) PH22924A (fr)
PT (1) PT84041B (fr)
SE (1) SE451840B (fr)
SG (1) SG117292G (fr)
ZA (1) ZA868600B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9111010B (sl) * 1990-06-07 2005-02-28 Astrazeneca Ab 3,5-disubstituirani indolni derivati kot "5-HT1-podobni" receptorski agonisti
US5834490A (en) * 1993-11-04 1998-11-10 Instituto De Investigacion Y Desarrolo Quimico Biologico, S.A. Cyclopropyl derivatives, preparation method there-of and applications
ES2082703B1 (es) * 1993-11-04 1996-12-16 Inst Investigacion Desarrollo Nuevos derivados de ciclopropilo, procedimientos para su preparacion y aplicaciones.
KR100393133B1 (ko) * 1994-09-23 2003-11-17 다윈 디스커버리 리미티드 레보부피바카인및그의유사체의제조에사용하는라세미화및비대칭변환방법
SE9501808D0 (sv) * 1995-05-16 1995-05-16 Astra Ab New process
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
SE9800139D0 (sv) 1998-01-21 1998-01-21 Astra Ab New use
BRPI0104491B8 (pt) * 2001-10-10 2021-05-25 Cristalia Produtos Quim Farmaceuticos Ltda n-(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida; processo de obtenção dos enantiômeros; mistura não racêmica dos anantiômeros e seu processo de obtenção e composição farmacêutica.
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
US7683175B2 (en) * 2005-06-06 2010-03-23 Navinta, Llc Process of making optically pure L-pipecolic acid and process of making anesthetics and intermediates therefrom
US20090187024A1 (en) * 2006-04-25 2009-07-23 Dishman Pharmaceuticals And Chemicals Ltd. Ropivacaine hydrochloride anhydrate and the preparation thereof
WO2009089841A1 (fr) * 2008-01-15 2009-07-23 Pharmathen S.A. Procédé de préparation d'un composé (s)-1-alkyl-2',6'-pipécoloxylidide
US8473062B2 (en) 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
US9320908B2 (en) 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
CN102093284B (zh) * 2010-12-29 2013-05-08 宜昌人福药业有限责任公司 富集哌啶-2-甲酰苯胺类旋光化合物的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2248018A (en) * 1939-03-30 1941-07-01 Winthrop Chem Co Inc 4-aryl-piperidine-ketones and a process of preparing them
GB775749A (en) * 1955-04-06 1957-05-29 Bofors Ab Method of preparing amides of n-alkyl piperidine monocarboxylic acid and n-alkyl pyrrolidine -a-monocarboxylic acid
GB775750A (en) * 1955-04-28 1957-05-29 Bofors Ab Method of preparing amides of n-alkyl piperidine mono-carboxylic acid and n-alkyl pyrrolidine -a-monocarboxylic acid
US2799679A (en) * 1955-04-28 1957-07-16 Bofors Ab Process of preparing amides of heterocyclic carboxylic acids
GB800565A (en) * 1956-01-23 1958-08-27 Bofors Ab Method of producing n-alkyl-piperidine-ª‡-monocarboxylic acid amides and n-alkyl-pyrrolidine-ª‡-monocarboxylic acid amides
GB824542A (en) * 1957-05-15 1959-12-02 Bofors Ab Method of producing n-alkyl-piperidine-alpha-monocarboxylic acid amides
GB869978A (en) * 1958-03-13 1961-06-07 Bofors Ab Method of producing n-alkyl-and-cycloalkyl-piperidine carboxylic acid amides
GB949729A (en) * 1960-11-15 1964-02-19 Bofors Ab Substituted-piperidine carboxylic acid amide salts and their preparation
SE341404B (fr) * 1967-05-18 1971-12-27 Sterling Drug Inc
CH491915A (de) * 1967-06-28 1970-06-15 Geigy Ag J R Verfahren zur Herstellung von neuen Piperidinderivaten
US3879382A (en) * 1971-08-27 1975-04-22 Teijin Ltd Process for the recovery of D- or L-{60 -amino-{68 -caprolactam hydrochloride of enhanced optical purity from mixtures of D- and L-{60 -amino-{68 -caprolactam hydrochloride
SE7607114L (sv) * 1976-06-22 1977-12-23 Bofors Ab Sett att framstella hydrokloriden av n-metylpiperidin-2-karbonsyra-2,6-xyllidid
SE431092B (sv) * 1979-07-10 1984-01-16 Thuresson Af Ekenstam Bo Terapeutiskt aktiva, substituerade piperidinkarboxianilider
JPS60502054A (ja) * 1983-08-01 1985-11-28 アストラ・レケメデル・アクチボラグ Ｌ―Ｎ―ｎ―プロピルピペコリン酸―２，６―キシリダイドおよびその製造方法

Also Published As

Publication number Publication date
NO864858D0 (no) 1986-12-03
EG17867A (en) 1991-03-30
NO864858L (no) 1987-07-06
DK287A (da) 1987-07-04
EP0239710A1 (fr) 1987-10-07
NZ218615A (en) 1989-07-27
ES2036179T3 (es) 1993-05-16
JPH07598B2 (ja) 1995-01-11
DK171378B1 (da) 1996-10-07
KR870007118A (ko) 1987-08-14
US4870086A (en) 1989-09-26
SE8600017D0 (sv) 1986-01-03
PT84041A (en) 1987-01-01
NO1997009I1 (no) 1997-08-18
FI870003A0 (fi) 1987-01-02
AU592392B2 (en) 1990-01-11
BG62066B2 (bg) 1999-01-29
NO170330C (no) 1992-10-07
SG117292G (en) 1993-01-29
NL960005I1 (nl) 1996-09-02
ATE56956T1 (de) 1990-10-15
SE451840B (sv) 1987-11-02
LU88843I2 (fr) 1997-03-14
PH22924A (en) 1989-01-24
JPS62158251A (ja) 1987-07-14
IE59061B1 (en) 1993-12-15
MY101132A (en) 1991-07-31
CY1680A (en) 1993-10-10
NO170330B (no) 1992-06-29
ZA868600B (en) 1987-08-26
AU6644986A (en) 1987-07-09
LV5765B4 (lv) 1997-06-20
SE8600017L (sv) 1987-07-04
AR242561A1 (es) 1993-04-30
KR940008302B1 (ko) 1994-09-12
DK287D0 (da) 1987-01-02
EP0239710B1 (fr) 1990-09-26
CA1276154C (fr) 1990-11-13
LV5765A4 (lv) 1996-12-20
FI83075B (fi) 1991-02-15
FI870003L (fi) 1987-07-04
PT84041B (pt) 1989-09-14
GR3002516T3 (en) 1993-01-25
DE3674582D1 (de) 1990-10-31
NL960005I2 (nl) 1997-10-01
IE870004L (en) 1987-07-03
FI83075C (fi) 1991-05-27

Similar Documents

Publication Publication Date Title
EP0239710B1 (fr) (S)-(-)-1-propyl-2',6'-pipécoloxylidide chlorohydrate monohydrate, son procédé de préparation et médicament le contenant
FI80020C (fi) Foerfarande foer framstaellning av en terapeutiskt aktiv l-n-n-propylpipekolsyra-2,6-xylidid.
WO1999052525A1 (fr) Thienylazolylalcoxyethanamines, leur preparation et leur application en tant que medicaments
CA2024572A1 (fr) 4-pyrimidinamines et pyrimidinediamines substituees en n, procede depreparation et utilisation comme medicaments
EP0755398B1 (fr) Procede de resolution de l'etodolac a l'aide de derives de la glucamine
KR910004599A (ko) 1,3-디하이드로-1-(피리디닐아미노)-2h-인돌-2-온, 이들의 제조방법 및 이들의 약제로서의 용도
JP2003535885A (ja) 制御された範囲内にｐＨを持つ安定なギャバペンチン
JPS6051172A (ja) ピロリジノン誘導体
JPH0585933A (ja) 白内障治療用薬剤
KR0147834B1 (ko) (+-)-시스 또는 (+-)-트란스-퍼메트르산의 광학 분할법
CA2022484A1 (fr) 1-(pyridinylamina)-2-pyrrolidinones, procede de preparation et utilisation comme medicaments
HUT45039A (en) Process for producing new benzhydryl-piperazine derivatives and pharmaceuticals comprising the compounds
CA2301739A1 (fr) Analogues optiquement purs de la camptothecine, intermediaire de synthese optiquement pur et son procede de preparation
SI8711067A8 (en) Process for obtaining monohydrate of optically pure s-(-)-1 propyl-2',6' pipecoloxylidid chlorinehydrate
CN105924382B (zh) S-马尼地平盐酸盐i晶型及其制备方法
SU1447283A3 (ru) Способ получени конденсированных производных @ S-триазина
KR100295255B1 (ko) 피롤리디닐메틸인돌의염
CN1023009C (zh) 一种旋光纯化合物的制备方法
JPS59176260A (ja) ８−アミノ−２−メチル−４−フエニル−１，２，３，４−テトラヒドロイソキノリンの光学対掌体
CN121085803A (zh) 一种贝达喹啉类化合物及其制备方法
HU198689B (en) Process for producing optically pure s-/-/-1-propyl-2'6'-pipekoloxilidiol-gidrokhloride-monohydrate and pharmaceutical compositions containing them
PL150293B1 (pl) spo sOb wytwarzania praktycznie optycznie czystego jednowodzianu chlorowodorku 2,6-DWUMETYLOANILIDU KWASU S-/-/-1-PROPYLOPIPEKOLINOWEGO
JPS6169750A (ja) ヒドロキシフエノキシプロパノールアミン類、その製法及びそれを含む医薬組成物
JPH08169877A (ja) 光学的活性の１−置換２−（アミノメチル）ピロリジンの製法
IE45480B1 (en) N-2,6-dichlorophenyl-2-aminopyrimidine and therapeutic compositions containing it

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20061214